Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care
Sign Up to like & getrecommendations! Published in 2023 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.13136
Abstract: During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir was only approved for hospitalized patients. Our institution developed hospital‐based, outpatient infusion centers for selected hospitalized patients with COVID‐19 who had clinical improvement to… read more here.
Keywords: treated remdesivir; clinical outcomes; remdesivir across; remdesivir ... See more keywords